Abstract
Metastatic gastric cancer remains a frequent disease with spontaneous median survival of about 6 months [1]. FAM regimen (5-FU, Doxorubicin and Mitomycin) was until the nineteens, considered as standard treatment of advanced gastric cancer. Recent publication of EORTC data showed significant improvement of survival in patients treated with FAMTX (5-FU, Methotrexate, Doxorubicin) in comparison to FAM [11].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Allum WH, Powell DJ, McConkey CC, Fielding JW (1989) Gastric cancer: a 25 years review. Br J Surg 76: 535–540
Cullinan SA, Moertel CG, Fleming TR et al (1985) A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil v.s. Fluorouracil and Doxorubicin v.s. Fluorouracil, Doxorubicin and Mitomycin. JAMA 253: 2061–2067
De Lisi V, Cocconi G, Tonato M et al (1986) Randomized comparison of 5-FU alone or combined with Carmustine, Doxorubicin and Mitomycin (BAFMi) in the treatment of advanced gastric cancer. A phase III trial of the Italian Clinical Research Oncology Group (GOIRC). Cancer Treatm Rep 70: 481–485
Kelsen D, Atiq OT, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V, Brennan M (1992) FAMTX versus Etoposide, Doxorubicin and Cisplatin: a random assignment trial in gastric cancer. J Clin Oncol 10, 4: 541–548
Lacave A J, Buesa JM, Gracia JM et al (1989) Cisplatin and 5-Fluorouracil in the treatment of advanced gastric cancer. Abstr. EORTC Symp Adv in Gastrointest Tract Cancer Res and Treatm 44
Machover D, Golfschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg, Fourtillan JB, Gaget H, Mathe G (1986) Treatment of advanced colorectal and gastric adenocarcinomas with 5-Fluorouracil and high-dose folinic acid. J Clin Oncol 4, 5: 685–696
Preusser P, Wilke H, Achterrath W et al (1989) Phase II study with the combination Etoposide, Doxorubicin and Cisplatin in advanced measurable gastric cancer. J Clin Oncol 7: 1310–1317
Rougier Ph, Mahjoubi M, Oliveira J et al (1989) Treatment of advanced gastric adenocarcinoma (AGC) with 5-FU/platinum combination. Abstr. EORTC Symp Adv in Gastrointest Tract Research and Treatm 45
Wilke H, Preusser P, Fink U, Achterrath W, Lenaz L, Stahl M, Schober C, Link H, Meyer HJ, Lücke B, Schmoll HJ (1990) High-dose folinic Acid/Etopo-side/5-Fluorouracil in advanced gastric cancer — a phase II study in elderly patients or patients with cardiac risk. Investigational New Drugs 8: 65–70
Wilke H, Preusser P, Fink U, Stahl M, Meyer HJ, Achterrath W, Köhne-Wömpner CH, Schöber Ch, Harstrick A, Lenaz L, Meyer J, Schmoll HJ (1991) Pilot study with Folnic Acid, Etoposide, 5-Fluorouracil, and Cisplatin in advanced gastric and esophageal cancer. Tumordiag. u. Ther 12: 21–24
Wils JA, Klein HO, Wagener DJ et al (1991) Sequential high-dose Methotrexate and Fluorouracil combined with Doxorubicin — a step ahead in the treatment of advanced gastric cancer: a trial of European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 9: 827–831
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag France
About this paper
Cite this paper
Ychou, M. et al. (1994). Combination of 5-FU, Leucovorin and Cisplatin (CDDP): an efficient low-toxic chemotherapy in advanced gastric adenocarcinoma. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Cancer Treatment An Update. Springer, Paris. https://doi.org/10.1007/978-2-8178-0765-2_83
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0765-2_83
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0767-6
Online ISBN: 978-2-8178-0765-2
eBook Packages: Springer Book Archive